当前位置: 首页 > 详情页

miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Peoples R China; [2]Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp,Lab Neurooncol, Tianjin 300060, Peoples R China; [3]Minist Educ, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300060, Peoples R China; [4]Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [5]Tianjin Municipal Govt, Tianjin 300060, Peoples R China; [6]Tianjin Neurol Inst, Lab Neurooncol, 152 Anshan Rd, Tianjin 300052, Peoples R China
出处:
ISSN:

关键词: miR-137 Glioma Cox-2

摘要:
MicroRNAs are strongly implicated in cancer but their specific roles and functions in the major cancers have yet to be fully elucidated. In this study, we defined the expression and function of miR-137, which we found to be downregulated in glioma samples and glioma cells by qRT-PCR. Ectopic expression of miR-137 in glioma cell lines inhibited proliferation and invasion. Using computational and expression analysis, Cox-2 was identified as a candidate target of miR-137. Reporter assay with 30UTR of Cox-2 cloned downstream of the luciferase gene showed reduced luciferase activity in the presence of miR-137, providing strong evidence that miR-137 was a direct regulator of Cox-2. Expression analysis further revealed that Cox-2 was elevated in glioma and associated with survival of patients. Furthermore, we observed that Cox-2 knockdown resulted in effects similar to those with miR-137 transfection in glioma cells. In conclusion, our study demonstrates that miR-137 deregulation is common in glioma, and restoration of its function inhibits cell proliferation and invasion, suggesting that miR-137 may act as a tumour suppressor. (C) 2012 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2010]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Peoples R China;
通讯作者:
通讯机构: [2]Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp,Lab Neurooncol, Tianjin 300060, Peoples R China; [3]Minist Educ, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300060, Peoples R China; [5]Tianjin Municipal Govt, Tianjin 300060, Peoples R China; [6]Tianjin Neurol Inst, Lab Neurooncol, 152 Anshan Rd, Tianjin 300052, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院